Show simple item record

dc.contributor.authorAliasghari, F
dc.contributor.authorIzadi, A
dc.contributor.authorJabbari, M
dc.contributor.authorImani, B
dc.contributor.authorGargari, BP
dc.contributor.authorAsjodi, F
dc.contributor.authorEbrahimi, S
dc.date.accessioned2018-08-26T08:35:20Z
dc.date.available2018-08-26T08:35:20Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52638
dc.description.abstractBackground: Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of insulin resistance, is the most common cause of chronic liver. The present study aimed to investigate the roles of Vaspin and omentin-1 in the NAFLD-related pathology including IR, inflammation and elevated blood pressure. Methods: This cross-sectional study was conducted among 83 NAFLD patients in Jahrom, Iran. Plasma levels of omentin-1, Vaspin, hs-CRP and IL-6 were measured. Anthropometric indices, lipid profiles, liver enzymes as well as abdominal ultrasonography were assessed. Results: Partial correlations controlling for age and sex showed significant positive correlation between Vaspin and fasting blood sugar (FBS), insulin, HOMA-IR, and hs-CRP. It has been observed that omentin negatively correlated with glucose levels. Moreover, a marginally significant association has been found between Omentin levels and systolic blood pressure (SBP). Conclusions: This study shows that Vaspin and Omentin-1 are associated with inflammation, insulin resistance and serum glucose levels in patients with NAFLD. é 2018 Fereshteh Aliasghari et al., published by De Gruyter Open.
dc.language.isoEnglish
dc.relation.ispartofJournal of Medical Biochemistry
dc.titleAre Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients?
dc.typeArticle
dc.citation.spage1
dc.citation.epage6
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.2478/jomb-2018-0006


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record